WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001087916) A NOVEL PEPTIDE---HUMAN RIBOSOMAL PROTEIN S5-13 AND THE POLYNUCLEOTIDE CODING THIS NOVEL PEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/087916    International Application No.:    PCT/CN2001/000725
Publication Date: 22.11.2001 International Filing Date: 08.05.2001
IPC:
C07K 14/47 (2006.01)
Applicants: SHANGHAI BIOWINDOW GENE DEVELOPMENT INC. [CN/CN]; 12th Floor 3rd Building No. 1111 Zhongshan Bei Er Road Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: SHANGHAI HUA DONG PATENT AGENCY; 319 Yue Yang Road Shanghai 200031 (CN)
Priority Data:
00115645.4 09.05.2000 CN
Title (EN) A NOVEL PEPTIDE---HUMAN RIBOSOMAL PROTEIN S5-13 AND THE POLYNUCLEOTIDE CODING THIS NOVEL PEPTIDE
(FR) NOUVEAU POLYPEPTIDE, PROTEINE RIBOSOMALE HUMAINE S5-13, ET POLYNUCLEOTIDE CODANT POUR CE POLYPEPTIDE
Abstract: front page image
(EN)The invention discloses a novel peptide---Human ribosomal protein S5-13, polynucleotide coding this peptide and the method producing this peptide by DNA recombination techniques. This invention also discloses the therapeutical methods with this peptide for several diseases, such as malignant tumor, haemal illness, HIV infection, immunological illness and all kinds of inflammations, et al. This invention also discloses an antagonist against this peptide and its therapeutical effect. The invention also discloses the use of this polynucleotide coding the novel human ribosomal protein S5-13.
(FR)L'invention concerne un nouveau polypeptide, une protéine ribosomale humaine S5-13, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la protéine ribosomale humaine S5-13.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)